New Products

COLUMBUS, Ohio — Roxane Labs on Tuesday announced the introduction of doxercalciferol capsules, available in strengths of 0.5-mcg, 1-mcg, and 2.5-mcg in 50-count bottles for immediate shipment to wholesalers and pharmacies across the nation.  

Doxercalciferol is used to lower elevated parathyroid hormone levels in patients who undergo kidney dialysis. Roxane Labs’ doxercalciferol capsules is AB Rated in the Food and Drug Administration Orange Book to Hectorol (doxercalciferol) capsules, 0.5-mcg, 1-mcg, and 2.5-mcg.

NEW YORK — Lawmakers in Florida are looking into ways to ease regulatory limitations for telemedicine in an effort to increase access to care and create “a fertile ground” for the technology to be used, according to a local report.

NOVATO, Calif. — 4ThoughtProducts has announced the release of Pill Pod, a new safety device that serves as a "keyless" drug lock box for use in the home.

GREENSBORO, N.C. — Merz North America recently launched Mederma PM, a new one-of-a-kind scar cream formulated to work at night, when skin naturally regenerates faster.  

Mederma PM Intensive Overnight Scar Cream is formulated to complement this nighttime activity with Tripeptol, a skin-nourishing complex with peptides, collagen and antioxidants to promote healthy-looking skin and help skin fight free radical damage. 

LAKE FOREST, Ill. — Pharmacy automation provider Kirby Lester on Thursday went live with its new online store. 

Kirby Lester maintains one of the largest markets of automatic tablet/capsule counter sales in the United States. 

SLOUGH, England — Reckitt Benckiser has line extended its Mucinex franchise into the year-round allergy sector with Mucinex Allergy, Heather Allen, Reckitt Benckiser EVP category development, told analysts Wednesday. 

"Super fantastic launch in the U.S.," she said. "Allergy is a $2.5 billion market in the U.S. More than 75% of Mucinex users also take an allergy treatment, and now, we're able to offer them Mucinex Allergy, maximum strength, non-drowsy antihistamine, acts fast and lasts for 24 hours."

JERUSALEM — Teva Pharmaceutical Industries on Thursday announced that the Food and Drug Administration has granted full approval of Synribo (omacetaxine mepesuccinate) for injection.

The drug is indicated for adult patients with chronic phase or accelerated phase chronic myeloid leukemia with resistance and/or intolerance to two or more tyrosine kinase inhibitors.

FORT COLLINS, Colo. — An Indiegogo crowdfunding campaign has recently been launched to help raise funds to produce an at-home beverage organizer system.

Cupsy features two removable and adjustable legs, two cupholders and additional space between the cupholders for personal items, as well as two flip-down stemware holders.